CDC advisory panel recommends resuming use of J&J vaccine with label warning

An advisory panel for the Centers for Disease Control and Prevention voted in favor of resuming the Johnson & Johnson vaccination with a label warning about rare blood clots.

April 23, 2021

Top Stories

ABC News Live Presents